Position in FATE
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$22,228
+$11,980 QoQ
Shares Held
18,524
+77.1% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026R Squared Ltd holds $2,636,359 across 23 Biotechnology names. FATE ranks #20 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
15,351 | $736,387 | |
| 2 | ARGX |
Argenx SE
|
539 | $393,604 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
4,359 | $327,317 | |
| 4 | FOLD |
AMICUS THERAPEUTICS, INC.
|
15,178 | $219,473 | |
| 5 | ALLO |
Allogene Therapeutics, Inc.
|
45,245 | $110,397 | |
| 6 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
67,526 | $105,340 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
32,363 | $99,354 | |
| 8 | BCYC |
Bicycle Therapeutics PLC
|
21,057 | $97,704 |
All Filings in FATE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,228 | 18,524 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $10,248 | 10,458 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $22,590 | 17,929 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $990 | 600 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||